AC
Insider buying
Adar1 Capital Management, Llc bought $722K of InMed Pharmaceuticals Inc. (INM) stock
Adar1 Capital Management, Llc, 10% owner of InMed Pharmaceuticals Inc. (INM), bought 468,551 shares of INM stock worth $722K, per an SEC Form 4 filed May 21, 2026.
It was an open-market purchase.
The trade happened on May 19, 2026, 2 days before it was made public.
- Traded
- May 19, 2026
- Disclosed
- May 21, 2026
- Filing delay
- 2 days
- Role
- 10% owner
- Source
- SEC Form 4
More INM insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.